Pillstats
Rx only · Tablet, Film Coated · Oral

Canagliflozin And Metformin Hydrochloride

Brands: Invokamet · Canagliflozin + Metformin Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6809
US makers1 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.75$5.50$8.26$11.01Dec 2025Apr 2026Jul 2026
$9.571
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5371.1K1.6K2.1K2025 Q12025 Q22025 Q32025 Q42026 Q1
835
Rx · 2026 Q1
73K
Units dispensed
-55%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Janssen Pharmaceuticals, Inc.unknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Oct 19, 2016
    RECALLRecall (Class III): Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manuf…

    Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert. — Recalling firm: Janssen Ortho L.L.C. — Nationwide and Puerto Rico